Talphera (TLPH) Total Current Liabilities (2010 - 2026)
Talphera (TLPH) posted quarterly Total Current Liabilities of $4.0 million for Q1 2026, up 102.36% year-over-year from $2.0 million in Q1 2025, and up 5.67% quarter-over-quarter from $3.8 million in Q4 2025.
Talphera (TLPH) Total Current Liabilities (2010 - 2026) Analysis & Trends
Talphera's Total Current Liabilities history runs 17 years deep, the most recent figure standing at $4.0 million for Q1 2026.
- In Q1 2026, Total Current Liabilities rose 102.36% year-over-year to $4.0 million; the TTM figure through Mar 2026 stood at $4.0 million (up 102.36% YoY), while the FY2025 annual figure was $3.8 million, up 43.9% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $4.0 million, up from $3.8 million in the prior quarter.
- The five-year high for Total Current Liabilities was $17.7 million in Q2 2022, with the low at $2.0 million in Q1 2025.
- The 5-year median for Total Current Liabilities is $3.8 million (2025), against an average of $6.7 million.
- The sharpest annual moves came in 2023 and 2026: Total Current Liabilities tumbled 77.16% in 2023, then surged 102.36% in 2026.
- Talphera's Total Current Liabilities stood at $13.8 million in 2022, then sank by 67.23% to $4.5 million in 2023, then tumbled by 41.33% to $2.6 million in 2024, then jumped by 43.9% to $3.8 million in 2025, then gained by 5.67% to $4.0 million in 2026.
- Business Quant data shows TLPH's Total Current Liabilities at $4.0 million in Q1 2026, $3.8 million in Q4 2025, and $3.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 1.79 Bn |
| 10 | Talphera | 89.95 Mn | 89.95 Mn | - | 4.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.19 Mn |
| Mar 31, 2026 | 4.03 Mn |
| Dec 31, 2025 | 3.81 Mn |
| Sep 30, 2025 | 3.21 Mn |
| Jun 30, 2025 | 2.63 Mn |
| Mar 31, 2025 | 1.99 Mn |
| Dec 31, 2024 | 2.65 Mn |
| Sep 30, 2024 | 2.76 Mn |
| Jun 30, 2024 | 3.27 Mn |
| Mar 31, 2024 | 3.34 Mn |
| Dec 31, 2023 | 4.51 Mn |
| Sep 30, 2023 | 3.57 Mn |
| Jun 30, 2023 | 4.22 Mn |
| Mar 31, 2023 | 9.46 Mn |
| Dec 31, 2022 | 13.77 Mn |
| Sep 30, 2022 | 15.65 Mn |
| Jun 30, 2022 | 17.69 Mn |
| Mar 31, 2022 | 17.03 Mn |
| Dec 31, 2021 | 18.51 Mn |
| Sep 30, 2021 | 17.07 Mn |